BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2212374)

  • 1. The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate.
    Bassan MM
    J Am Coll Cardiol; 1990 Oct; 16(4):936-40. PubMed ID: 2212374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
    Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
    Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
    Thadani U; Fung HL; Darke AC; Parker JO
    Am J Cardiol; 1982 Feb; 49(2):411-9. PubMed ID: 7058754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the day-long antianginal effectiveness of nitroglycerin patches with that of three-times-daily isosorbide dinitrate: a double-blind study using dose titration.
    Bassan MM; Rogel S
    Eur Heart J; 1992 Sep; 13(9):1265-70. PubMed ID: 1396839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The day-long antianginal effectiveness of nitroglycerin patches. A double-blind study using dose-titration.
    Bassan M
    Chest; 1991 May; 99(5):1120-5. PubMed ID: 1902159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.
    Parker JO; Farrell B; Lahey KA; Moe G
    N Engl J Med; 1987 Jun; 316(23):1440-4. PubMed ID: 3574424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
    Rao YV; Reddy KS; Wasir HS
    Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
    Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy of nisoldipine, metoprolol, and isosorbide dinitrate in patients with stable exertional angina: a randomized, cross-over, placebo-controlled study.
    Ogawa H; Yasue H; Nakamura N; Fujii H; Miyagi H; Kikuta K
    Int J Cardiol; 1995 Feb; 48(2):131-7. PubMed ID: 7774991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
    Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
    Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate tolerance.
    Parker JO
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
    Parker JO; VanKoughnett KA; Fung HL
    Am J Cardiol; 1984 Jul; 54(1):8-13. PubMed ID: 6430057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
    Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
    Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal effect of isosorbide dinitrate spray in patients with exercise-induced stable angina.
    Aärynen M; Soininen K
    J Int Med Res; 1986; 14(6):303-5. PubMed ID: 3803701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment.
    Sussex BA; Campbell NR; Raju MK; McKay DW
    Clin Pharmacol Ther; 1994 Aug; 56(2):229-34. PubMed ID: 8062500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.
    van de Ven LL; Vermeulen A; Tans JG; Tans AC; Liem KL; Lageweg NC; Lie KI
    Int J Cardiol; 1995 Jan; 47(3):217-23. PubMed ID: 7721498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study.
    Liang CS; Coplin B; Wellington K
    Am J Cardiol; 1985 May; 55(12):9E-14E. PubMed ID: 4003286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.